Tammy Pelegrin
Family · Oxford, MSNPI 1073893624
Payments from drug & device makers
Across 117 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$210
- E.r. Squibb & Sons, L.L.C.$176
- Pharmacyclics LLC, An Abbvie Company$155
- Novartis$139
- Merck$100
- Lilly USA, LLC$80
- plus $1K from 30 others
What the payments were for
- Food & beverage$1,897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 13 | $210 |
| E.r. Squibb & Sons, L.L.C. | 12 | $176 |
| Pharmacyclics LLC, An Abbvie Company | 8 | $155 |
| Novartis | 10 | $139 |
| Merck | 6 | $100 |
| Lilly USA, LLC | 4 | $80 |
| Amgen | 5 | $78 |
| Eisai Inc. | 4 | $69 |
| AstraZeneca(2 entities) | 4 | $68 |
| Johnson & Johnson | 5 | $63 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Pfizer | 4 | $57 |
| Bristol Myers Squibb | 3 | $48 |
| Sanofi | 2 | $48 |
| Bayer | 3 | $46 |
| AMAG Pharmaceuticals, Inc. | 3 | $45 |
| Incyte Corporation | 3 | $43 |
| Exelixis Inc. | 3 | $41 |
| GSK | 2 | $34 |
| Coherus Oncology, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Deciphera Pharmaceuticals Inc. | 2 | $25 |
| Puma Biotechnology, Inc. | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $17 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
| AbbVie | 1 | $17 |
| Gilead | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Morphosys, US Inc. | 1 | $14 |
| Acceleron Pharma, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $11 |
| Array Biopharma Inc | 1 | $11 |
How this compares
$1,897 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 52 | $132 |
Paid to pharmacies, not to this prescriber.
Other family in Oxford
- Shannon FryeryOxford$127K
- Penny BurchamOxford$22K
- Anna WiygulOxford$15K
- Erin SmithOxford$13K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.